{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:32:41Z","timestamp":1792006361585,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T00:00:00Z","timestamp":1572825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Energy restriction reduces liver fat, improves hepatic insulin resistance and lipid metabolism. However, temporal data in which these metabolic improvements occur and their interplay is incomplete. By performing repeated MRI scans and blood analysis at day 0, 3, 7, 14 and 28 the temporal changes in liver fat and related metabolic factors were assessed at five times during a low-calorie diet (LCD, 800\u20131100\u2009kcal\/day) in ten obese non-diabetic women (BMI 41.7\u2009\u00b1\u20092.6\u2009kg\/m<jats:sup>2<\/jats:sup>) whereof 6 had NAFLD. Mean weight loss was 7.4\u2009\u00b1\u20091.2\u2009kg (0.7\u2009kg\/day) and liver fat decreased by 51\u2009\u00b1\u200916%, resulting in only three subjects having NAFLD at day 28. Marked alteration of insulin, NEFA, ALT and 3-hydroxybuturate was evident 3 days after commencing LCD, whereas liver fat showed a moderate but a linear reduction across the 28 days. Other circulating-liver fat markers (e.g. triglycerides, adiponectin, stearoyl-CoA desaturase-1 index, fibroblast growth factor 21) demonstrated modest and variable changes. Marked elevations of NEFA, 3-hydroxybuturate and ALT concentrations occurred until day 14, likely reflecting increased tissue lipolysis, fat oxidation and upregulated hepatic fatty acid oxidation. In summary, these results suggest linear reduction in liver fat, time-specific changes in metabolic markers and insulin resistance in response to energy restriction.<\/jats:p>","DOI":"10.1038\/s41387-019-0100-2","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T16:03:06Z","timestamp":1572883386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Energy restriction in obese women suggest linear reduction of hepatic fat content and time-dependent metabolic improvements"],"prefix":"10.1038","volume":"9","author":[{"given":"Hans-Erik","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Edholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Rosqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Rudling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Straniero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Anders","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Ahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6243-2859","authenticated-orcid":false,"given":"Magnus","family":"Sundbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Ris\u00e9rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,4]]},"reference":[{"key":"100_CR1","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl, A. M. & Day, C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N. Engl. J. Med. 377, 2063\u20132072. (2017).","journal-title":"N. Engl. J. Med."},{"key":"100_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"100_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry, R. J., Samuel, V. T., Petersen, K. F. & Shulman, G. I. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510, 84\u201391 (2014).","journal-title":"Nature"},{"key":"100_CR4","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2017.13","volume":"6","author":"HPF Peters","year":"2017","unstructured":"Peters, H. P. F. et al. Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. J. nutritional Sci. 6, e15 (2017).","journal-title":"J. nutritional Sci."},{"key":"100_CR5","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/oby.2009.171","volume":"17","author":"BE Vitola","year":"2009","unstructured":"Vitola, B. E. et al. Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents. Obesity 17, 1744\u20131748 (2009).","journal-title":"Obesity"},{"key":"100_CR6","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1007\/s00125-011-2204-7","volume":"54","author":"EL Lim","year":"2011","unstructured":"Lim, E. L. et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54, 2506\u20132514 (2011).","journal-title":"Diabetologia"},{"key":"100_CR7","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/imj.13973","volume":"48","author":"ES George","year":"2018","unstructured":"George, E. S. et al. Non alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia; high risk status and low prevalence. Intern. Med. J. 48, 1369\u20131376 (2018).","journal-title":"Intern. Med. J."},{"key":"100_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0766-3","volume":"14","author":"MF Xia","year":"2016","unstructured":"Xia, M. F. et al. The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women. J. Transl. Med. 14, 11 (2016).","journal-title":"J. Transl. Med."},{"key":"100_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02677-9","volume":"9","author":"H Li","year":"2018","unstructured":"Li, H. et al. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat. Nat. Commun. 9, 272 (2018).","journal-title":"Nat. Commun."},{"key":"100_CR10","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3945\/ajcn.111.030114","volume":"95","author":"H Bjermo","year":"2012","unstructured":"Bjermo, H. et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am. J. Clin. Nutr. 95, 1003\u20131012 (2012).","journal-title":"Am. J. Clin. Nutr."},{"key":"100_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4291\/wjgp.v8.i2.11","volume":"8","author":"F Hadizadeh","year":"2017","unstructured":"Hadizadeh, F., Faghihimani, E. & Adibi, P. Nonalcoholic fatty liver disease: diagnostic biomarkers. World J. Gastrointest. Pathophysiol. 8, 11\u201326 (2017).","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"100_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.soard.2014.07.018","volume":"11","author":"D Edholm","year":"2015","unstructured":"Edholm, D. et al. Changes in liver volume and body composition during 4 weeks of low calorie diet before laparoscopic gastric bypass. Surg. Obes. Relat. Dis. 11, 602\u2013606 (2015).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"100_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostatis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"100_CR14","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.3390\/nu7115454","volume":"7","author":"H Yki-Jarvinen","year":"2015","unstructured":"Yki-Jarvinen, H. Nutritional modulation of non-alcoholic fatty liver disease and insulin resistance. Nutrients 7, 9127\u20139138 (2015).","journal-title":"Nutrients"},{"key":"100_CR15","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.2337\/db13-1622","volume":"63","author":"F Rosqvist","year":"2014","unstructured":"Rosqvist, F. et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 63, 2356\u20132368 (2014).","journal-title":"Diabetes"},{"key":"100_CR16","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1111\/j.1478-3231.2009.02076.x","volume":"29","author":"A Kotronen","year":"2009","unstructured":"Kotronen, A. et al. Liver fat and lipid oxidation in humans. Liver Int. 29, 1439\u20131446 (2009).","journal-title":"Liver Int."},{"key":"100_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2337\/diab.24.1.10","volume":"24","author":"NJ Grey","year":"1975","unstructured":"Grey, N. J., Karl, I. & Kipnis, D. M. Physiologic mechanisms in the development of starvation ketosis in man. Diabetes 24, 10\u201316 (1975).","journal-title":"Diabetes"},{"key":"100_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s12020-014-0192-3","volume":"47","author":"B Moreno","year":"2014","unstructured":"Moreno, B. et al. Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity. Endocrine 47, 793\u2013805 (2014).","journal-title":"Endocrine"},{"key":"100_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cmet.2016.09.001","volume":"24","author":"SM Solon-Biet","year":"2016","unstructured":"Solon-Biet, S. M. et al. Defining the nutritional and metabolic context of FGF21 using the geometric framework. Cell Metab. 24, 555\u2013565 (2016).","journal-title":"Cell Metab."},{"key":"100_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","volume":"57","author":"X Zhang","year":"2008","unstructured":"Zhang, X. et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57, 1246\u20131253 (2008).","journal-title":"Diabetes"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-019-0100-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-019-0100-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-019-0100-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T14:52:21Z","timestamp":1671202341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-019-0100-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,4]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1038\/s41387-019-0100-2","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,4]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"34"}}